QuidelOrtho Corp
QDEL- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001906324
No open-market purchases or sales by QuidelOrtho Corp insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q3 2026, worth $863.5M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $656.6M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, 0 vs. previous quarter
- 242
- 13F valueReported value at the end of Q3 2026
- $863.5M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $2.73B
- −1.9% year over year
- Net income, FY2025
- -$1.13B
- No comparable prior period
- Free cash flow, FY2025
- -$83.0M
- No comparable prior period
- Revenue, Q3 FY2026
- $618.9M
- −11.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $1.13B (41.5% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 14.5M
- Shares sold short
- Change
- +1.47M
- +11.3% vs. previous
- Days to cover
- 7.60
- At average daily volume
Superinvestors holding QDEL, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding QDEL at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by QuidelOrtho Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 13 | 6 days | Busky Joseph MChief Financial Officer | PPurchase | +3.37K | $23.66 | +$79.7K | +48.7%10.3K after | Amended |
| Feb 13, 2026 (view filing) | Feb 13 | Same day | Blaser Brian JPresident and CEO | PPurchase | +10.5K | $23.59 | +$248.6K | +35.7%40.1K after | |
| Feb 13, 2026 (view filing) | Feb 13 | Same day | Strobeck MatthewDirector | PPurchase | +10.0K | $23.96 | +$239.6K | +56.3%27.8K after | |
| Dec 10, 2025 (view filing) | Dec 10 | Same day | Rhoads Ann DDirector | PPurchase | +750 | $28.28 | +$21.2K | +5.3%15.0K after | |
| Dec 1, 2025 (view filing) | Nov 26 | 5 days | Wilkins Joseph D Jr.Director | PPurchase | +370 | $27.96 | +$10.3K | +3.2%11.9K after | |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Busky Joseph MChief Financial Officer | PPurchase | +4.77K | $26.06 | +$124.3K | +221.9%6.92K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Widder Kenneth JDirector | SSale | −4.03K | $27.81 | −$112.0K | −9.8%37.1K after | |
| Nov 24, 2025 (view filing) | Nov 21 | 3 days | Polan Mary Lake PH DDirector | PPurchase | +1.00K | $22.43 | +$22.4K | +8.6%12.6K after | |
| Nov 20, 2025 (view filing) | Nov 19 | 1 day | Blaser Brian JPresident and CEO | PPurchase | +23.5K | $21.34 | +$501.5K | +389.5%29.5K after | |
| Dec 13, 2024 (view filing) | Dec 11 | 2 days | Blaser Brian JPresident and CEO | PPurchase | +6.03K | $41.42 | +$249.9K | New position6.03K after |
Top 10 13F holders, Q3 2026
See all 242 holdersThe largest institutional positions in QuidelOrtho Corp at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11,143,003 | $117.4M | 0.00% | −59,520−0.5% | Reduced |
| Newtyn Management, LLC | 5,342,283 | $56.3M | 7.72% | −1,282,717−19.4% | Reduced |
| FMR LLC | 3,950,168 | $41.6M | 0.00% | −3,413,528−46.4% | Reduced |
| American Century Companies Inc | 3,926,634 | $41.4M | 0.02% | +619,555+18.7% | Added |
| Vanguard Portfolio Management LLC | 3,635,778 | $38.3M | 0.00% | −499,686−12.1% | Reduced |
| Invesco Ltd. | 3,604,814 | $38.0M | 0.00% | +131,382+3.8% | Added |
| Rubric Capital Management LP | 3,133,148 | $33.0M | 0.31% | −173,133−5.2% | Reduced |
| State Street Corp | 3,026,630 | $31.9M | 0.00% | +47,991+1.6% | Added |
| Vanguard Capital Management LLC | 3,015,589 | $31.8M | 0.00% | −54,465−1.8% | Reduced |
| Neuberger Berman Group LLC | 2,949,874 | $31.1M | 0.02% | −584,745−16.5% | Reduced |
Holders of 5% or more of QDEL
See all 8 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of QuidelOrtho Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 14.80%10.0M shares | +2.30 ppfrom 12.50% | Oct 7, 20243 filings | Jul 17, 2025 | SEC |
| Newtyn Management, LLC | 13G/A | 7.80%5.34M shares | −1.90 ppfrom 9.70% | May 6, 20264 filings | Nov 16, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 6.00%4.09M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| FMR LLC | 13G/A | 5.80%3.95M shares | −5.70 ppfrom 11.50% | Nov 5, 20255 filings | Oct 7, 2026 | SEC |
| American Century Investment Management Inc | 13G | 5.70%3.93M shares | New | Nov 16, 20261 filing | Nov 16, 2026 | SEC |
Politician trades
All politician trades in QDEL4 members of Congress reported 14 trades in QuidelOrtho Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 13, 2023 | Daniel S. Goldman House · NY | Sell | $1K-$15K |
| Jun 23, 2021 | Tom Malinowski House · NJ | Buy | $15K-$50K |
| Jun 12, 2021 | Tom Malinowski House · NJ | Sell | $1K-$15K |
| Apr 10, 2021 | Tom Malinowski House · NJ | Sell | $1K-$15K |
| Apr 10, 2021 | Tom Malinowski House · NJ | Sell | $15K-$50K |

House · NY · Aug 13, 2023
Sell$1K-$15K

House · NJ · Jun 23, 2021
Buy$15K-$50K

House · NJ · Jun 12, 2021
Sell$1K-$15K

House · NJ · Apr 10, 2021
Sell$1K-$15K

House · NJ · Apr 10, 2021
Sell$15K-$50K